Screener
Pfizer PFE Return on equity
Return on equity at other companies
Other financials
Where this comes from
Calculated from Pfizer’s reported figures.
Based on trailing twelve months.
The source filing: Pfizer’s 10-Q, filed November 4, 2025. Open the filing →
- Filed
- Nov 4, 2025
- Fiscal quarter
- Q3 FY2025
- Calendar quarter
- Q3 2025
- Accession
- 0000078003-25-000150
FAQ
- What is Pfizer's return on equity?
- Pfizer (PFE) reported return on equity of 10.6% in Q3 2025.
- What is the long-term trend for Pfizer's return on equity?
- Over 3 years (2020 to 2024), Pfizer's return on equity has grown at a -14.5% compound annual growth rate (CAGR), from 14.5% to 9.1%.
- What does return on equity mean?
- Trailing-twelve-month net income divided by average shareholders' equity (average of the start and end of the trailing-twelve-month window). Measures the profit generated on each dollar of shareholder capital.
Ask your AI about Pfizer's return on equity.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude